Szerző: " Majláth Zsófia"

Hal Melinda; Hal Viktor; Vécsei László; Balog Anna; Majláth Zsófia; Tajti János; Ertsey Csaba; Bozsik György; Zsombók Terézia Ibolya; Purebl György: Personality traits and psychological complaints under patients suffering from headaches.
IDEGGYOGYASZATI SZEMLE / CLINICAL NEUROSCIENCE, 76 (11-12). pp. 385-393. ISSN 0019-1442 (2023)

Majláth Zsófia; Szalárdy Levente; Zádori Dénes; Klivényi Péter; Fülöp Ferenc; Toldi József; Vécsei László: Neuroprotection by Kynurenine Metabolites.
In: Handbook of Neurotoxicity. Springer, Cham, pp. 1067-1080. (2022) ISBN 9783031150791; 9783031150807

Petrovics-Balog Anna; Majláth Zsófia; Lukács Melinda; Holczer Adrienn; Must Anita; Tajti János; Vécsei László: The effect of psychiatric comorbidities and stress-coping strategies on perceived quality of life in migraine.
IDEGGYOGYASZATI SZEMLE / CLINICAL NEUROSCIENCE, 72 (11-12). pp. 397-404. ISSN 0019-1442 (2019)

Majláth Zsófia; Annus Ádám; Vécsei László: Kynurenine System and Multiple Sclerosis, Pathomechanism and Drug Targets with An Emphasis on Laquinimod.
CURRENT DRUG TARGETS, 19 (7). pp. 805-814. ISSN 1389-4501 (2018)

Rajda Cecília; Pukoli Dániel; Bende Zsuzsanna; Majláth Zsófia; Vécsei László: Excitotoxins, mitochondrial and redox disturbances in multiple sclerosis.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 18 (2). Terjedelem: 28 p-Azonosító: 353. ISSN 1661-6596 (2017)

Majláth Zsófia; Obál Izabella; Vécsei László: Treatment possibilities for psychosis in Parkinson's disease with an emphasis on the newly approved drug: Pimavanserin.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 16 (3). pp. 234-243. ISSN 1871-5273 (2017)

Tajti János; Szok Délia; Majláth Zsófia; Csáti Anett; Petrovics-Balog Anna; Vécsei László: Alleviation of pain in painful diabetic neuropathy.
Expert Opinion on Drug Metabolism and Toxicology, 7. pp. 753-764. ISSN 1742-5255 (2016)

Török Nóra; Majláth Zsófia; Fülöp Ferenc; Toldi József; Vécsei László: Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism.
CURRENT DRUG METABOLISM, 17 (5). pp. 412-429. ISSN 1389-2002 (2016)

Majláth Zsófia; Toldi József; Fülöp Ferenc; Vécsei László: Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa-Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System.
Current Medicinal Chemistry, 23 (9). pp. 874-883. ISSN 0929-8673 (2016)

Török Nóra; Majláth Zsófia; Szalárdy Levente; Vécsei László: Investigational α-synuclein aggregation inhibitors: hope for Parkinson’s disease.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 25 (11). pp. 1281-1294. ISSN 1354-3784 (2016)

Majláth Zsófia; Török Nóra; Toldi József; Vécsei László: Memantine and kynurenic acid: Current neuropharmacological aspects.
CURRENT NEUROPHARMACOLOGY, 14 (2). pp. 200-209. ISSN 1570-159X (2016)

Majláth Zsófia; Török Nóra; Toldi József; Vécsei László: Promising therapeutic agents for the treatment of Parkinson’s disease.
EXPERT OPINION ON BIOLOGICAL THERAPY, 16 (6). pp. 787-799. ISSN 1471-2598 (2016)

Varga Noémi; Csapó Edit; Majláth Zsófia; Ilisz István; Krizbai István Adorján; Wilhelm Imola Mária; Knapp Levente; Toldi József; Vécsei László; Dékány Imre: Targeting of the kynurenic acid across the blood-brain barrier by core-shell nanoparticles.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 86. pp. 67-74. ISSN 0928-0987 (2016)

Csapó Edit; Bogár Ferenc; Juhász Ádám; Sebők Dániel; Szolomájer János; Tóth Gábor; Majláth Zsófia; Vécsei László; Dékány Imre: Determination of binding capacity and adsorption enthalpy between Human Glutamate Receptor (GluR1) peptide fragments and kynurenic acid by surface plasmon resonance experiments. Part 2: Interaction of GluR1270–300 with KYNA.
Colloids and Surfaces B: Biointerfaces, 132. pp. 66-72. ISSN 0927-7765 (2015)

Vécsei László; Majláth Zsófia; Szok Délia; Csáti Anett; Tajti János: Drug safety and tolerability in prophylactic migraine treatment.
Expert Opinion on Drug Safety, 14 (5). pp. 667-681. ISSN 1474-0338 (2015)

Tajti János; Majláth Zsófia; Szok Délia; Csáti Anett; Vécsei László: Drug safety in acute migraine treatment.
Expert Opinion on Drug Safety, 14 (6). pp. 891-909. ISSN 1474-0338 (2015)

Vécsei László; Majláth Zsófia; Petrovics-Balog Anna; Tajti János: Drug targets of migraine and neuropathy: treatment of hyperexcitability.
CNS AND NEUROLOGICAL DISORDERS-DRUG TARGETS, 14 (5). pp. 664-676. ISSN 1871-5273 (2015)

Lukács Melinda; Haanes Kristian Agmund; Majláth Zsófia; Tajti János; Vécsei László; Warfvinge Karin; Edvinsson Lars: Dural administration of inflammatory soup or Complete Freund’s Adjuvant induces activation and inflammatory response in the rat trigeminal ganglion.
JOURNAL OF HEADACHE AND PAIN, 16 (1). Azonosító: 79-Terjedelem: 11 p.. ISSN 1129-2369 (2015)

Rajda Cecília; Majláth Zsófia; Pukoli Dániel; Vécsei László: Kynurenines and multiple sclerosis: The dialogue between the immune system and the central nervous system.
International Journal of Molecular Sciences, 16 (8). pp. 18270-18282. ISSN 1661-6596 (2015)

Tajti János; Szok Délia; Majláth Zsófia; Tuka Bernadett; Csáti Anett; Vécsei László: Migraine and neuropeptides.
Neuropeptides, 52. pp. 19-30. ISSN 0143-4179 (2015)

Tajti János; Majláth Zsófia; Szok Délia; Csáti Anett; Toldi József; Fülöp Ferenc; Vécsei László: Novel kynurenic Acid Analogues in the Treatment of Migraine and Neurodegenerative Disorders: Preclinical Studies and Pharmaceutical Design.
CURRENT PHARMACEUTICAL DESIGN, 21 (17). pp. 2250-2258. ISSN 1381-6128 (2015)

Majláth Zsófia; Vécsei László: Stress and the kynurenine pathway.
Orvosi Hetilap, 156 (35). pp. 1402-1405. ISSN 0030-6002 (2015)

Csapó Edit; Majláth Zsófia; Juhász Ádám; Roósz Balázs; Hetényi Anasztázia; Tóth Gábor; Tajti János; Vécsei László; Dékány Imre: Determination of binding capacity and adsorption enthalpy between Human Glutamate Receptor (GluR1) peptide fragments and kynurenic acid by surface plasmon resonance experiments.
Colloids and Surfaces B: Biointerfaces, 123. pp. 924-929. ISSN 0927-7765 (2014)

Majláth Zsófia; Vécsei László: NMDA antagonists as Parkinson's disease therapy: disseminating the evidence.
Neurodegenerative disease management, 4 (1). pp. 23-30. ISSN 1758-2024 (2014)

Majláth Zsófia; Toldi József; Vécsei László: The potential role of kynurenines in Alzheimer’s disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors.
Journal of Neural Transmission, 121 (8). pp. 881-889. ISSN 0300-9564 (2014)

Majláth Zsófia; Vécsei László: Kinureninek idegrendszeri kórképekben: terápiás perspektívák.
Élet és Tudomány, 68 (17). pp. 527-529. ISSN 0013-6077 (2013)

Majláth Zsófia; Tajti János; Vécsei László: Kynurenines and other novel therapeutic strategies in the treatment of dementia.
Therapeutic Advances in Neurological Disorders, 6 (6). pp. 386-397. ISSN 1756-2856 (2013)

Majláth Zsófia; Ajtay András; Bereczki Dániel; Csiba László; Komoly Sámuel; Vécsei László: Neurology in Hungary: past, present, and future.
Neurology, 80 (16). pp. 1518-1520. ISSN 0028-3878 (2013)

Plangár Imola; Majláth Zsófia; Vécsei László: Kynurenines in cognitive functions: their possible role in depression.
NEUROPSYCHOPHARMACOLOGIA HUNGARICA, 14 (4). pp. 239-244. ISSN 1419-8711 (2012)